Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Biora Therapeutics Inc

CUSIP: 74319F905 | 4 institutional holders

Quarters

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile